Annual Total Long Term Liabilities
$879.28 M
+$446.47 M+103.15%
December 31, 2023
Summary
- As of February 7, 2025, NVAX annual total long term liabilities is $879.28 million, with the most recent change of +$446.47 million (+103.15%) on December 31, 2023.
- During the last 3 years, NVAX annual total long term liabilities has risen by +$503.68 million (+134.10%).
- NVAX annual total long term liabilities is now at all-time high.
Performance
NVAX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.06 B
-$34.62 M-3.17%
September 30, 2024
Summary
- As of February 7, 2025, NVAX quarterly total long term liabilities is $1.06 billion, with the most recent change of -$34.62 million (-3.17%) on September 30, 2024.
- Over the past year, NVAX quarterly long term liabilities has increased by +$191.00 million (+22.03%).
- NVAX quarterly long term liabilities is now -25.30% below its all-time high of $1.42 billion, reached on March 31, 2024.
Performance
NVAX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NVAX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +103.2% | +22.0% |
| 3 y3 years | +134.1% | +96.6% |
| 5 y5 years | +166.2% | +217.6% |
NVAX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.2% | -25.3% | +144.4% |
| 5 y | 5-year | at high | +163.9% | -25.3% | +217.6% |
| alltime | all time | at high | >+9999.0% | -25.3% | >+9999.0% |
Novavax Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.06 B(-3.2%) |
| Jun 2024 | - | $1.09 B(-22.9%) |
| Mar 2024 | - | $1.42 B(+61.1%) |
| Dec 2023 | $879.28 M(+103.2%) | $879.28 M(+1.4%) |
| Sep 2023 | - | $866.92 M(+2.8%) |
| Jun 2023 | - | $843.31 M(+62.4%) |
| Mar 2023 | - | $519.42 M(+20.0%) |
| Dec 2022 | $432.81 M(-19.6%) | $432.81 M(-62.9%) |
| Sep 2022 | - | $1.17 B(+31.9%) |
| Jun 2022 | - | $883.70 M(+73.8%) |
| Mar 2022 | - | $508.55 M(-5.5%) |
| Dec 2021 | $538.11 M(+43.3%) | $538.11 M(+53.2%) |
| Sep 2021 | - | $351.19 M(-0.4%) |
| Jun 2021 | - | $352.51 M(-2.3%) |
| Mar 2021 | - | $360.68 M(-4.0%) |
| Dec 2020 | $375.60 M(+12.7%) | $375.60 M(-37.2%) |
| Sep 2020 | - | $598.36 M(+12.0%) |
| Jun 2020 | - | $534.37 M(+60.4%) |
| Mar 2020 | - | $333.06 M(-0.0%) |
| Dec 2019 | $333.18 M(+0.8%) | $333.18 M(+0.0%) |
| Sep 2019 | - | $333.07 M(-0.1%) |
| Jun 2019 | - | $333.39 M(-2.1%) |
| Mar 2019 | - | $340.41 M(+3.0%) |
| Dec 2018 | $330.37 M(-0.1%) | $330.37 M(-0.0%) |
| Sep 2018 | - | $330.44 M(-0.0%) |
| Jun 2018 | - | $330.50 M(-0.0%) |
| Mar 2018 | - | $330.53 M(-0.0%) |
| Dec 2017 | $330.55 M(-0.9%) | $330.55 M(-2.8%) |
| Sep 2017 | - | $339.95 M(-2.3%) |
| Jun 2017 | - | $347.98 M(+4.2%) |
| Mar 2017 | - | $334.11 M(+0.2%) |
| Dec 2016 | $333.44 M(+1875.9%) | $333.44 M(-0.2%) |
| Sep 2016 | - | $334.16 M(+0.3%) |
| Jun 2016 | - | $333.01 M(-0.9%) |
| Mar 2016 | - | $336.02 M(+1891.2%) |
| Dec 2015 | $16.88 M(+37.6%) | $16.88 M(+32.4%) |
| Sep 2015 | - | $12.74 M(+26.9%) |
| Jun 2015 | - | $10.04 M(-3.1%) |
| Mar 2015 | - | $10.36 M(-15.6%) |
| Dec 2014 | $12.27 M(-10.9%) | $12.27 M(+0.3%) |
| Sep 2014 | - | $12.23 M(-4.3%) |
| Jun 2014 | - | $12.78 M(-7.5%) |
| Mar 2014 | - | $13.82 M(+0.4%) |
| Dec 2013 | $13.77 M(+32.0%) | $13.77 M(-3.3%) |
| Sep 2013 | - | $14.24 M(+14.5%) |
| Jun 2013 | - | $12.44 M(+4.7%) |
| Mar 2013 | - | $11.88 M(+13.9%) |
| Dec 2012 | $10.43 M | $10.43 M(+19.5%) |
| Sep 2012 | - | $8.73 M(+34.8%) |
| Jun 2012 | - | $6.48 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $6.47 M(+25.7%) |
| Dec 2011 | $5.15 M(-6.9%) | $5.15 M(-10.4%) |
| Sep 2011 | - | $5.75 M(+40.9%) |
| Jun 2011 | - | $4.08 M(-25.6%) |
| Mar 2011 | - | $5.48 M(-0.9%) |
| Dec 2010 | $5.53 M(-27.5%) | $5.53 M(+97.9%) |
| Sep 2010 | - | $2.79 M(-3.7%) |
| Jun 2010 | - | $2.90 M(-3.5%) |
| Mar 2010 | - | $3.00 M(-60.6%) |
| Dec 2009 | $7.63 M(+123.0%) | $7.63 M(+137.1%) |
| Sep 2009 | - | $3.22 M(-2.8%) |
| Jun 2009 | - | $3.31 M(-0.8%) |
| Mar 2009 | - | $3.34 M(-2.4%) |
| Dec 2008 | $3.42 M(-84.5%) | $3.42 M(+6.8%) |
| Sep 2008 | - | $3.20 M(-86.9%) |
| Jun 2008 | - | $24.53 M(+11.0%) |
| Mar 2008 | - | $22.10 M(+0.4%) |
| Dec 2007 | $22.02 M(-2.3%) | $22.02 M(-0.8%) |
| Sep 2007 | - | $22.21 M(+0.3%) |
| Jun 2007 | - | $22.14 M(-2.1%) |
| Mar 2007 | - | $22.60 M(+0.3%) |
| Dec 2006 | $22.54 M(-24.5%) | $22.54 M(-0.4%) |
| Sep 2006 | - | $22.63 M(-0.4%) |
| Jun 2006 | - | $22.71 M(-0.3%) |
| Mar 2006 | - | $22.78 M(-23.7%) |
| Dec 2005 | $29.85 M(-17.4%) | $29.85 M(-16.9%) |
| Sep 2005 | - | $35.94 M(-0.1%) |
| Jun 2005 | - | $35.97 M(-0.2%) |
| Mar 2005 | - | $36.05 M(-0.2%) |
| Dec 2004 | $36.14 M(-16.7%) | $36.14 M(-0.2%) |
| Sep 2004 | - | $36.21 M(-16.1%) |
| Jun 2004 | - | $43.17 M(-0.2%) |
| Mar 2004 | - | $43.27 M(-0.2%) |
| Dec 2003 | $43.38 M(-0.4%) | $43.38 M(-0.2%) |
| Sep 2003 | - | $43.48 M(-0.3%) |
| Jun 2003 | - | $43.59 M(-0.3%) |
| Mar 2003 | - | $43.75 M(+0.4%) |
| Dec 2002 | $43.57 M(+33.5%) | $43.57 M(+2.7%) |
| Sep 2002 | - | $42.44 M(-0.1%) |
| Jun 2002 | - | $42.50 M(+30.5%) |
| Mar 2002 | - | $32.56 M(-0.2%) |
| Dec 2001 | $32.63 M(+63.1%) | $32.63 M(-0.2%) |
| Sep 2001 | - | $32.69 M(+43.7%) |
| Jun 2001 | - | $22.75 M(+13.8%) |
| Mar 2001 | - | $20.00 M(0.0%) |
| Dec 2000 | $20.00 M(>+9900.0%) | $20.00 M(>+9900.0%) |
| Dec 1999 | $100.00 K(-200.0%) | $100.00 K(0.0%) |
| Sep 1999 | - | $100.00 K(-200.0%) |
| Dec 1998 | -$100.00 K | -$100.00 K(-200.0%) |
| Jun 1997 | - | $100.00 K |
FAQ
- What is Novavax annual total long term liabilities?
- What is the all time high annual total long term liabilities for Novavax?
- What is Novavax annual total long term liabilities year-on-year change?
- What is Novavax quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Novavax?
- What is Novavax quarterly long term liabilities year-on-year change?
What is Novavax annual total long term liabilities?
The current annual total long term liabilities of NVAX is $879.28 M
What is the all time high annual total long term liabilities for Novavax?
Novavax all-time high annual total long term liabilities is $879.28 M
What is Novavax annual total long term liabilities year-on-year change?
Over the past year, NVAX annual total long term liabilities has changed by +$446.47 M (+103.15%)
What is Novavax quarterly total long term liabilities?
The current quarterly long term liabilities of NVAX is $1.06 B
What is the all time high quarterly long term liabilities for Novavax?
Novavax all-time high quarterly total long term liabilities is $1.42 B
What is Novavax quarterly long term liabilities year-on-year change?
Over the past year, NVAX quarterly total long term liabilities has changed by +$191.00 M (+22.03%)